Beta Agonist Lung Injury TrIal (BALTI) Prevention Study
Completed
- Conditions
- Oesophageal cancerCancerMalignant neoplasm of the oesophagus
- Registration Number
- ISRCTN47481946
- Lead Sponsor
- Birmingham Heartlands Hospital (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
1. Planned elective transthoracic oesophagectomy patients
2. Aged greater than 18 years
3. Male and female
4. Able to provide informed consent
5. Able to use a spacer device to deliver the drug
Exclusion Criteria
1. Pregnancy
2. Current treatment with long acting beta agonist
3. Allergy to excipients in salmeterol
4. Current treatment with non-cardioselective beta-blockers
5. Treatment with investigational medicinal product (IMP) in the last 30 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method